Stock Information
Gilead Sciences Inc (GILD)
Ticker Symbol: GILD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $173,335.35 mil
Piotroski score: 8
PE Ratio: 20.2699
EPS (TTM): 6.7844
Revenue (TTM): $23.52 M
Dividend Yield: 2.3083960869871%
ROE: 41.02%
Latest News
-
Gilead price target raised to $175 from $171 at Morgan Stanley
Sat, Apr 11, 2026 12:57 PM
-
Trump policies, China's biotech boom are ending Europe's pharma powerhouse era
Sat, Apr 11, 2026 1:54 AM
-
Gilead’s Tubulis Deal Recasts Oncology Ambitions And HIV Reliance Risks
Sat, Apr 11, 2026 12:24 AM
-
AHF Slams Gilead for Role in Florida AIDS Drug Crisis
Fri, Apr 10, 2026 5:01 PM
-
KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200
Fri, Apr 10, 2026 4:04 PM
-
Morgan Stanley Maintains Overweight on Gilead Sciences, Raises Price Target to $175
Fri, Apr 10, 2026 11:13 AM
-
RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders
Fri, Apr 10, 2026 11:10 AM
-
Gilead Expands Partnership With Tempus AI To Power Cancer Discoveries
Fri, Apr 10, 2026 6:50 AM
-
Gilead Sciences (GILD) to Acquire Tubulis for $5B to Strengthen Oncology Pipeline
Fri, Apr 10, 2026 4:43 AM
-
PLTR, RIVN Gain Favor As INTC Momentum Fades
Thu, Apr 9, 2026 10:24 PM
Key Financials
Financial data not available
